Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells

Mercedes B. Fuertes(University of Chicago), Aalok Kacha(University of Chicago), Justin Kline(University of Chicago), Seng‐Ryong Woo(University of Chicago), David M. Kranz(University of Illinois Urbana-Champaign), Kenneth M. Murphy(Washington University in St. Louis), Thomas F. Gajewski(University of Chicago)
The Journal of Experimental Medicine
September 19, 2011
Cited by 1,172Open Access
Full Text

Abstract

Despite lack of tumor control in many models, spontaneous T cell priming occurs frequently in response to a growing tumor. However, the innate immune mechanisms that promote natural antitumor T cell responses are undefined. In human metastatic melanoma, there was a correlation between a type I interferon (IFN) transcriptional profile and T cell markers in metastatic tumor tissue. In mice, IFN-β was produced by CD11c(+) cells after tumor implantation, and tumor-induced T cell priming was defective in mice lacking IFN-α/βR or Stat1. IFN signaling was required in the hematopoietic compartment at the level of host antigen-presenting cells, and selectively for intratumoral accumulation of CD8α(+) dendritic cells, which were demonstrated to be essential using Batf3(-/-) mice. Thus, host type I IFNs are critical for the innate immune recognition of a growing tumor through signaling on CD8α(+) DCs.


Related Papers